Add to favorite
Scientists of the Chemical Biology and Fundamental Medicine Institute, RAS, are developing a new coformulated drug for fighting oncology. It will combine the vaccinia virus and breast milk proteins, which are individually displayed in the destruction of cancer cells.
Valentin Vlasov, member of the Russian Academy of Sciences.
"Oncolytic viruses are based on the vaccinia virus." Besides, there is an original genetic engineering drug based on the protein [of breast milk] - lactaptin - and able to suppress the development of certain tumors and metastases. we are developing a combination drug, which produces protein in addition. "We intend to provide this virus with additional weapons for the destruction of cancer cells", - academic Vlasov pointed out.
Sources: http://tass.ru
Author: Vera Ivanova
